“The aim [of this book] is to bear witness that God is still performing healing miracles today that transcend human reasoning and understanding, offer a source of inspiration and hope to those seeking an answer, solution or miracle from God, and proclaim that His mercy, grace, and power is the same, today, tomorrow, and forever,” said Calderón.
M. Ricardo Calderón, MD, MPH, FPMER, was born in Guatemala, Central America. He is a physician executive, educator, and global health expert with over 25 years of experience in senior leadership, representation, advisory services, and management of public, private, academic, research, pharmaceutical, faith-based, and non-profit organizations in over 20 countries. He was educated and trained in five universities in Guatemala (USAC) and the United States (UCLA, USC, CSUN, UNC).
Xulon Press, a division of Salem Media Group, is the world’s largest Christian self-publisher, with more than 20,000 titles published to date. Healed is available online through xulonpress.com/bookstore, amazon.com, and barnesandnoble.com.
Media Contact
M. Ricardo CalderSn, MD, MPH, FPMER., Salem Author Services, +502-3062-5646, mrcalderon@aol.com
WUXI, China, Oct. 2, 2023 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates its strategic partner, Amicus Therapeutics (“Amicus”) (Nasdaq: FOLD), on receiving U.S. FDA’s approval for…
WUXI, China, Oct. 1, 2023 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates its strategic partner, Amicus Therapeutics (“Amicus”) (Nasdaq: FOLD), on receiving U.S. FDA’s approval for…
STOCKHOLM, Oct. 1, 2023 /PRNewswire/ — RaySearch Laboratories AB (publ) is pleased to announce its expanded collaboration with P-Cure, aiming at enhancing the workflow efficiency of P-Cure’s proton therapy system through integration with RaySearch’s systems RayStation®* and RayCare®*….
NEW YORK, Oct. 1, 2023 /PRNewswire/ — The telemedicine market size is expected to grow by USD 92.07 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 15.64% during the forecast period, according to Technavio Research. The market is segmented by…
FARMINGTON HILLS, Mich., Oct. 1, 2023 /PRNewswire/ — Aesthetic Plastic Surgery & Laser Center, led by board-certified surgeon Dr. Michelle Hardaway, announces a rising trend in arm lift procedures, with a significant surge noticed among post-bariatric surgery patients and those using…
Providence Hospital, a fixture in west Mobile, will be known as USA Health Providence Hospital.
USA President Jo Bonner welcomed Providence to the University of South Alabama family. “We already share core values and a commitment to provide compassionate care to those who need it most,” Bonner said. “With your help, we will build upon our reputation for providing exceptional healthcare, education and research that transforms medicine in the Gulf Coast region.”
The acquisition includes Providence’s 349-bed hospital, eight clinics on the hospital campus, and six family practice sites in west and north Mobile and Moss Point, Mississippi. An estimated 1,800 Providence associates, physicians and other providers are now part of USA Health.
“We are very excited to welcome everyone at Providence to USA Health,” said John V. Marymont, M.D., M.B.A., vice president for medical affairs and dean of USA’sFrederick P. Whiddon College of Medicine. “To those who are graduates of the university or the medical school, we proudly say, ‘Welcome home.'”
USA Health and Providence have worked diligently to ensure a seamless transition for patients, physicians and associates. There will be no disruption in services or procedures. Todd Kennedy, M.B.A, MSHA, FACHE, who led Providence under Ascension, will serve as the hospital’s chief executive officer.
USA Health officials praised Providence’s excellent reputation and decades of service to the community. “Providence is well known for its rich history and culture, and we look forward to continuing that,” said Owen Bailey, MSHA, FACHE, chief executive officer for USA Health and senior associate vice president for medical affairs. “I have personally witnessed a great deal of excitement at both Providence and USA Health about our future together.”
USA Health is nationally recognized for its Level I trauma center, comprehensive stroke center, burn center, Level III NICU, center for maternal-fetal medicine and cancer treatment. Providence Hospital joins USA Health University Hospital and USA Health Children’s & Women’s Hospital as its third inpatient care facility. The acquisition also increases the number of USA Health’s locations from 29 to 44.
About USA Health USA Health is the only academic health system along the upper Gulf Coast. With its hospitals and physician practice sites throughout the area, the health system melds clinical care, research and healthcare education into the most advanced medical care in the region.
About the University of South Alabama The Flagship of the Gulf Coast, the University of South Alabama is a global teaching and research university that provides students with an exceptional education in business, the liberal arts, education, engineering, computing, the sciences and healthcare. USA’s commitment to student success includes small class sizes and hands-on research opportunities in more than 115 undergraduate, graduate and doctoral degree programs offered through 10 academic colleges and schools. USA offers advanced and innovative healthcare through the USA Health system of hospitals and clinics as well as the Frederick P. Whiddon College of Medicine.
App TENA Family Care tem como objetivo principal apoiar cuidadores familiares e profissionais para uma melhor partilha das tarefas e organização da rotina de cuidados, melhorando a qualidade de vida de todos. Lançamento ajuda os cuidadores de idosos e de pessoas fragilizadas a…
Plans feature expanded money-saving benefits that matter most to members WOONSOCKET, R.I., Oct. 1, 2023 /PRNewswire/ — Aetna®, a CVS Health® company (NYSE: CVS), announces our 2024 Medicare products ― the largest Medicare offering in our history1 ― featuring more choices, flexible…
P-Cure’s fully integrated, motion management, real-time approach combines a Six-Degree-of-Freedom robotic positioning system, constant radio- and fluoro-scopic imaging, and positioning software. As a result, the tumor will always be at the treatment’s iso-center.
Currently, for the first time in the history of proton therapy, patients are being treated within a vendor Clinical Development Center, clinically operated by the Hadassah Medical Center in Jerusalem. Working in partnership with Hadassah, recently named by Newsweek as a world leader in oncology, the hospital oncology department, including a full team of doctors, physicists, and dosimetrist, are bringing patients to the P-Cure facility to receive treatment in the only available proton facility in the Middle East.
Dr. Yoram Weiss, Director General, Hadassah Medical Organization said of the Newsweek recognition, “Our medical teams are increasingly recognized for their advances in research and for the quality of the care they provide in cardiology, oncology and many other areas as well as for their use of technology – an honor we in ‘Start-Up Nation’ especially relish.”
Prof. Aron Popovtzer, the Head of Sharett Institute of Oncology at the Hadassah Medical Center, said referring to the first patient treated, “We are thrilled to demonstrate the clinical benefits of Proton Therapy to patients having head and neck malignancies, emphasizing the importance of the patient’s comfort and quality of life as significant contributing factors to the positive clinical outcomes.”
Adult patients who will initially benefit from this clinical breakthrough will be those treated for cancers of the pancreas, chest, head and neck, and cranial tumors. Later, abdomen and pelvis cancer patients, as well as pediatric patients will gain access to this long-awaited treatment choice.
“The P-Cure proton system is fully ready for delivery to oncology centers interested in updating their cancer treatment options,” said Dr. Michael Marash, CEO of P-Cure. “The synchrotron-based gantry-less system can fit into Linac rooms, can easily be delivered to existing buildings using nothing more than the freight elevator, can be clinically ready to treat patients in a year after contracting, will cost about half of legacy systems, and will have reduced maintenance costs. The P-Cure Solution is a fully integrated comprehensive planning and treatment modality ready to expand patient access to proton therapy, will be somewhat immune to challenging reimbursement issues, as well as deliver a more rapid ROI.”
The treatment being delivered to Hadassah patients utilizes a unique feature of the P-Cure Proton Therapy System which enables diagnostic quality imaging capable of tracking changes occurring in a patient’s body during the treatment, especially in the tumor shape and location, as well as the position of healthy tissues around the tumor site. As such, this system’s versatility enables adjustment of the treatment plan in accordance with the new changing anatomy. This approach, called adaptive therapy, ensures that the treatment dose always covers the tumor without dangerous radiation to the healthy tissue and organs.
About P-Cure:
P-Cure Ltd., an Israel-based company, develops and supplies the most compact Proton Therapy solution for the targeted treatment of cancer with radiation. Founded in 2007, P-Cure has developed a comprehensive patient centric proton therapy solution with clinical benefits and financial advantages. The P-Cure mission is to provide proton therapy with greater treatment precision, enhanced clinical outcomes, and expanded treatment options. By significantly reducing the capital and operating costs, P-Cure expands the availability of proton therapy to all cancer care institutions and new facility developers worldwide.The P-Cure commitment is to put the patient first. For more information please visit: http://www.p-cure.com
About HADASSAH MEDICAL ORGANIZATION:
For more than a century, what became the Hadassah Medical Organization, the Jerusalem-based hospital system owned by Hadassah, The Women’s Zionist Organization of America, has set the standard for excellence in medical care and clinical research in Israel. The expertise, experience and ingenuity of Hadassah’s doctors and scientists have resulted in innovative solutions in all areas of medicine, including therapeutics, diagnostic tools, medical devices and digital health. In 2024, Newsweek named Hadassah a world leader in oncology, cardiology and smart technologies.
